Combined treatment eficacity of pre-myopes aged 11-14 years with familial factor
Închide
Articolul precedent
Articolul urmator
104 0
SM ISO690:2012
BÎLBA, Rodica, DUMBRĂVEANU, Lilia, CUSHNIR, V., CHIRIAC, Vera, CURCA, Stelian, COŞULA, Cristina, CECAN, Mihaela. Combined treatment eficacity of pre-myopes aged 11-14 years with familial factor. In: Perspectives of the Balkan medicine in the post COVID-19 era: The 37th Balkan Medical Week. The 8th congress on urology, dialysis and kidney transplant from the Republic of Moldova “New Horizons in Urology”, Ed. 37, 7-9 iunie 2023, Chişinău. București: Balkan Medical Union, 2023, Ediția 37, p. 209. ISSN Print: ISSN 1584-9244 ISSN-L 1584-9244 Online: ISSN 2558-815X.
EXPORT metadate:
Google Scholar
Crossref
CERIF

DataCite
Dublin Core
Perspectives of the Balkan medicine in the post COVID-19 era
Ediția 37, 2023
Congresul "Perspectives of the Balkan medicine in the post COVID-19 era"
37, Chişinău, Moldova, 7-9 iunie 2023

Combined treatment eficacity of pre-myopes aged 11-14 years with familial factor


Pag. 209-209

Bîlba Rodica, Dumbrăveanu Lilia, Cushnir V., Chiriac Vera, Curca Stelian, Coşula Cristina, Cecan Mihaela
 
”Nicolae Testemițanu” State University of Medicine and Pharmacy
 
 
Disponibil în IBN: 26 decembrie 2023


Rezumat

Introduction. The International Myopia Institute defines pre-myopia as “a refractive state of an eye of ≤ +0.75 D and > -0.50 D in children where a combination of baseline refraction, age, and other quantifiable risk factors provide a sufficient likelihood of the future development of myopia to merit preventative interventions.” Material and methods. Clinical retrospective study, that included 20 pre-myopes (40 eyes) aged 11-14 years with familial factor. The combined treatment (physiotherapy and anti-fatigue lensesRhein Vision’s Facile) was applied for 2 years. Results. In base group with familial factor, the spherical equivalent inreased (from 0.51 to +0,01 D) after 2 years of treatment. The vitreous chamber depth increased (from 17,06 to 17,37 mm). In control group with familial factor the spherical equivalent has increased (from +0,22 to -1.11 D) after 2 years of treatment. The vitreous chamber depth increased (from 16,45 to 16,90 mm) after 2 years. Between the basic group and control group, it was determined the statistical difference (p>0.05).Conclusions. The combined treatment has been proved to be an efficient method of prevention of myopia appearance.